Patient focused drug surveillance of elderly patients in nursing homes

Pharmacoepidemiology and Drug Safety

Volumn 19, Issue 2, 2010, Pages 150-157

  Olsson, Inger Nordin ^a   Curman, Bengt ^b   Engfeldt, Peter ^a,c  

^a ÖREBRO UNIVERSITY   (Sweden)

^b ÖREBRO UNIVERSITY HOSPITAL   (Sweden)

^c Öberbro County Council Medical Products Committee   (Sweden)

Author keywords

Drug evaluation; Elderly; Monitoring; Polypharmacy

Indexed keywords

ALBUMIN; CREATININE; CYSTATIN C; HEMOGLOBIN;

ADULT; AGED; ALBUMIN BLOOD LEVEL; ARTICLE; BLOOD PRESSURE; BODY WEIGHT; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DRUG SURVEILLANCE PROGRAM; EVALUATION; FEMALE; GERIATRIC PATIENT; GLOMERULUS FILTRATION RATE; HEALTH CARE QUALITY; HEALTH CARE UTILIZATION; HEALTH STATUS; HEMOGLOBIN BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; NURSING HOME PATIENT; OUTCOME ASSESSMENT; PHYSICIAN; POLYPHARMACY; PRIORITY JOURNAL; SWEDEN; TREATMENT WITHDRAWAL;

AGED; AGED, 80 AND OVER; DRUG MONITORING; FEMALE; FOLLOW-UP STUDIES; HEALTH SERVICES FOR THE AGED; HOMES FOR THE AGED; HUMANS; MALE; MIDDLE AGED; NURSING HOMES; POLYPHARMACY; SWEDEN;

EID: 76149089115     PISSN: 10538569     EISSN: 10991557     Source Type: Journal    
DOI: 10.1002/pds.1891     Document Type: Article

References (29)

1. The National Board of Health and Welfare. Läkemedelsbehandling inom äldrevården. In Socialstyrelsen (editor: Socialstyrelsen) Stockholm: Sweden. http://www.socialstyrelsen.se/NR/rdonlyres/F2DB1 284-162C-426C-BE00-E988CFB84A3A/2666/200410916.pdf 2004; 1-29.
2. The National Board of Health and Welfare. Uppföljning av äldres läkemedelsanvändning. In Socialstyrelsen (editor: Socialstyrelsen) Stockholm: Sweden. http://www.socialstyrelsen/se/NR/rdonlyres/ 6B9DA61E-F92C-46C8-BAC9-3A443EC1D2F8/3032/200410319.pdf 2004; 1-75.
3. Sloan RW. Principles of drug therapy in geriatric patients. Am Fam Physician 1992; 45: 2709-2718.
4. Cusack BJ. Pharmacokinetics in older persons. Am J Geriatr Pharmacother 2004; 2: 274-302.
5. Turnheim K. When drug therapy gets old: pharmacokinetics and pharmacodynamics in the elderly. Exp Gerontol 2003; 38: 843-853.
6. Yee JL, Hasson NK, Schreiber DH. Drug-related emergency department visits in an elderly veteran population. Ann Pharmacother 2005; 39: 1990-1995.
7. Beijer HJ, de Blaey CJ. Hospitalisations caused by adverse drug reactions (ADR): a meta-analysis of observational studies. Pharm World Sci 2002; 24: 46-54.
8. The National Board of Health and Welfare. Indikatorer för utvärdering av kvaliteten i äldres läkemedelsterapi. In Socialstyrelsen (editor: Socialstyrelsen) Stockholm: Sweden. http://www.socialstyrelsen.se/NR/rdonlyres/;1;A65367 AB-8F2A-4063-BC79- 13103784A838/986/200311020.pdf 2003; 1-74.
9. Fillit HM, Futterman R, Orland BI, et al. Polypharmacy management in Medicare managed care: changes in prescribing by primary care physicians resulting from a program promoting medication reviews. Am J Manag Care 1999; 5: 587-594.
10. Nazareth I, Burton A, Shulman S, Smith P, Haines A, Timberal H. A pharmacy discharge plan for hospitalized elderly patients - a randomized controlled trial. Age Ageing 2001; 30: 33-40.
11. Lenaghan E, Holland R, Brooks A. Home-based medication review in a high risk elderly population in primary care - the POLYMED randomised controlled trial. Age Ageing 2007; 36: 292-297.
12. Pacini M, Smith RD, Wilson EC, Holland R. Home-based medication review in older people: is it cost effective? Pharmacoeconomics 2007; 25: 171-180.
13. Holland R, Lenaghan E, Harvey I, et al. Does home based medication review keep older people out of hospital? The HOMER randomised controlled trial. Br Med J 2005; 330: 293.
14. Krska J, Cromarty JA, Arris F, et al. Pharmacist-led medication review in patients over 65: a randomized, controlled trial in primary care. Age Ageing 2001; 30: 205-211.
15. Zermansky AG, Petty DR, Raynor DK, Freemantle N, Vail A, Lowe CJ. Randomised controlled trial of clinical medication review by a pharmacist of elderly patients receiving repeat prescriptions in general practice. Br Med J 2001; 323: 1340-1343.
16. Salter C, Holland R, Harvey I, Henwood K. 'I haven't even phoned my doctor yet'. The advice giving role of the pharmacist during consultations for medication review with patients aged 80 or more: qualitative discourse analysis. Br Med J 2007; 334: 1101.
17. Gill SS, Misiaszek BC, Brymer C. Improving prescribing in the elderly: a study in the long term care setting. Can J Clin Pharmacol 2001; 8: 78-7883.
18. Crotty M, Halbert J, Rowett D, et al. An outreach geriatric medication advisory service in residential aged care: a randomised controlled trial of case conferencing. Age Ageing 2004; 33: 612-617.
19. King MA, Roberts MS. Multidisciplinary case conference reviews: improving outcomes for nursing home residents, carers and health professionals. Pharm World Sci 2001; 23: 41-45.
20. Bondesson A, Midlöv P, Eriksson T, Höglund P. Pharmacotherapeutic interventions by a multi-specialty team: opinions of the general practitioners and nurses. Eur J Clin Pharmacol 2003; 59: 65-69.
21. Midlöv P, Bondesson Å, Eriksson T, Nerbrand C, Höglund P. Effects of educational outreach visits on prescribing of benzodiazepines and antipsychotic drugs to elderly patients in primary health care in southern Sweden. Family practice 2006; 23: 60-64.
22. Larsson A, Malm J, Grubb A, Hansson LO. Calculation of glomerular filtration rate expressed in mL/min from plasma cystatin C values in mg/L. Scand J Clin Lab Invest 2004; 64: 25-30.
23. Sjöström P, Tidman M, Jones I. Determination of the production rate and non-renal clearance of cystatin C and estimation of the glomerular filtration rate from the serum concentration of cystatin C in humans. Scand J Clin Lab Invest 2005; 65: 111-124.
24. Russell MA, Hill KD, Blackberry I, Day LL, Dharmage SC. Falls risk and functional decline in older fallers discharged directly from emergency departments. J Gerontol A Biol Sci Med Sci 2006; 61: 1090-1095.
25. Turnheim K. Drug dosage in the elderly. Is it rational? Drugs Aging 1998; 13: 357-379.
26. Kuijpers MA, van Marum RJ, Egberts AC, Jansen PA. Relationship between polypharmacy and underprescribing. Br J Clin Pharmacol 2008; 65: 130-133.
27. Cleland JG, Baksh A, Louis A. Polypharmacy (or polytherapy) in the treatment of heart failure. Heart Fail Monit 2000; 1: 8-13.
28. Midlöv P, Bergkvist A, Bondesson A, Eriksson T, Höglund P. Medication errors when transferring elderly patients between primary health care and hospital care. Pharm World Sci 2005; 27: 116-120.
29. Garfinkel D, Zur-Gil S, Ben-Israel J. The war against polypharmacy: a new cost-effective geriatric-palliative approach for improving drug therapy in disabled elderly people. Isr Med Assoc J 2007; 9: 430-434.